T1	intervention 0 9	Tamoxifen
T2	eligibility 359 400	women at increased risk for breast cancer
T3	total-participants 598 604	13,388
T4	control 640 647	placebo
T6	outcome 1001 1042	cumulative rate of invasive breast cancer
T9	outcome 1190 1234	cumulative rate of noninvasive breast cancer
T12	iv-bin-percent 1461 1464	32%
T13	outcome 1465 1500	reduction in osteoporotic fractures
T14	outcome 1555 1561	stroke
T15	outcome 1563 1583	deep-vein thrombosis
T16	outcome 1589 1598	cataracts
T17	outcome 1639 1661	ischemic heart disease
T18	outcome 1666 1671	death
T19	outcome 1759 1786	Risks of pulmonary embolism
T7	cv-bin-abs 1060 1064	42.5
T20	control-participants 1069 1073	1000
T8	iv-bin-abs 1104 1108	24.8
T21	intervention-participants 1113 1117	1000
T10	cv-bin-abs 1252 1256	15.8
T22	control-participants 1261 1265	1000
T11	iv-bin-abs 1296 1300	10.2
T23	intervention-participants 1305 1309	1000
